Orilanolimab (Anti-FcRn (FCGRT & B2M))

Synonyms: SYNT001

Orilanolimab (Anti-FcRn (FCGRT & B2M)) is a humanized monoclonal antibody targeting FcRn. It disrupts the interaction of FcRn and IgG for the treatment autoimmune diseases. MW :144.28 KD.

Orilanolimab (Anti-FcRn (FCGRT & B2M))

Purity & Quality Control

Batch: A300001 Purity: 99% Protein concentration: 10.55mg/ml Endotoxin Level: <1EU/mg
99

Biological Activity

Description Orilanolimab (Anti-FcRn (FCGRT & B2M)) is a humanized monoclonal antibody targeting FcRn. It disrupts the interaction of FcRn and IgG for the treatment autoimmune diseases. MW :144.28 KD.

Product Details

CAS No. 2066544-85-0
Isotype Human IgG4SP
Source CHO
Formulation 100mMPro-Ac,20mMArg-Ac,pH5.0
Storage
(From the date of receipt)
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Comparison of Clones for

*Literature analysis of various clone (for this target) products available on the market shows that Selleck's selected clones are more frequently applied. (data until September 2024)

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Orilanolimab (Anti-FcRn (FCGRT & B2M)) | Orilanolimab (Anti-FcRn (FCGRT & B2M)) supplier | purchase Orilanolimab (Anti-FcRn (FCGRT & B2M)) | Orilanolimab (Anti-FcRn (FCGRT & B2M)) cost | Orilanolimab (Anti-FcRn (FCGRT & B2M)) manufacturer | order Orilanolimab (Anti-FcRn (FCGRT & B2M)) | Orilanolimab (Anti-FcRn (FCGRT & B2M)) distributor